Theseus Pharmaceuticals Statistics
Total Valuation
STERIS has a market cap or net worth of $23.24 billion. The enterprise value is $24.86 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Sep 4, 2025 |
Share Statistics
STERIS has 98.37 million shares outstanding. The number of shares has decreased by -0.48% in one year.
| Current Share Class | 98.37M |
| Shares Outstanding | 98.37M |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 94.56% |
| Float | 97.99M |
Valuation Ratios
The trailing PE ratio is 36.12 and the forward PE ratio is 22.97.
| PE Ratio | 36.12 |
| Forward PE | 22.97 |
| PS Ratio | 4.17 |
| Forward PS | 3.95 |
| PB Ratio | 3.33 |
| P/TBV Ratio | 25.00 |
| P/FCF Ratio | 25.57 |
| P/OCF Ratio | 18.38 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 16.61, with an EV/FCF ratio of 27.36.
| EV / Earnings | 38.45 |
| EV / Sales | 4.46 |
| EV / EBITDA | 16.61 |
| EV / EBIT | 24.34 |
| EV / FCF | 27.36 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.22 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.27 |
| Debt / FCF | 2.09 |
| Interest Coverage | 14.24 |
Financial Efficiency
Return on equity (ROE) is 9.74% and return on invested capital (ROIC) is 7.20%.
| Return on Equity (ROE) | 9.74% |
| Return on Assets (ROA) | 6.23% |
| Return on Invested Capital (ROIC) | 7.20% |
| Return on Capital Employed (ROCE) | 10.78% |
| Revenue Per Employee | $313,213 |
| Profits Per Employee | $36,355 |
| Employee Count | 17,787 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 4.63 |
Taxes
In the past 12 months, STERIS has paid $203.25 million in taxes.
| Income Tax | 203.25M |
| Effective Tax Rate | 23.83% |
Stock Price Statistics
The stock price has decreased by -1.23% in the last 52 weeks. The beta is 0.92, so STERIS's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -1.23% |
| 50-Day Moving Average | 234.55 |
| 200-Day Moving Average | 224.42 |
| Relative Strength Index (RSI) | 58.52 |
| Average Volume (20 Days) | 720,309 |
Short Selling Information
The latest short interest is 847,348, so 0.86% of the outstanding shares have been sold short.
| Short Interest | 847,348 |
| Short Previous Month | 728,308 |
| Short % of Shares Out | 0.86% |
| Short % of Float | 0.86% |
| Short Ratio (days to cover) | 1.49 |
Income Statement
In the last 12 months, STERIS had revenue of $5.57 billion and earned $646.64 million in profits. Earnings per share was $6.53.
| Revenue | 5.57B |
| Gross Profit | 2.47B |
| Operating Income | 1.02B |
| Pretax Income | 550.80M |
| Net Income | 646.64M |
| EBITDA | 1.50B |
| EBIT | 1.02B |
| Earnings Per Share (EPS) | $6.53 |
Full Income StatementBalance Sheet
The company has $279.70 million in cash and $1.90 billion in debt, giving a net cash position of -$1.62 billion or -$16.50 per share.
| Cash & Cash Equivalents | 279.70M |
| Total Debt | 1.90B |
| Net Cash | -1.62B |
| Net Cash Per Share | -$16.50 |
| Equity (Book Value) | 6.97B |
| Book Value Per Share | 70.85 |
| Working Capital | 1.13B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.26 billion and capital expenditures -$355.59 million, giving a free cash flow of $908.80 million.
| Operating Cash Flow | 1.26B |
| Capital Expenditures | -355.59M |
| Free Cash Flow | 908.80M |
| FCF Per Share | $9.24 |
Full Cash Flow StatementMargins
Gross margin is 44.36%, with operating and profit margins of 18.34% and 11.61%.
| Gross Margin | 44.36% |
| Operating Margin | 18.34% |
| Pretax Margin | 15.31% |
| Profit Margin | 11.61% |
| EBITDA Margin | 26.88% |
| EBIT Margin | 18.34% |
| FCF Margin | 16.31% |
Dividends & Yields
This stock pays an annual dividend of $2.28, which amounts to a dividend yield of 0.97%.
| Dividend Per Share | $2.28 |
| Dividend Yield | 0.97% |
| Dividend Growth (YoY) | 9.86% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 35.84% |
| Buyback Yield | 0.48% |
| Shareholder Yield | 1.44% |
| Earnings Yield | 2.78% |
| FCF Yield | 3.91% |
Dividend DetailsAnalyst Forecast
The average price target for STERIS is $265.88, which is 12.55% higher than the current price. The consensus rating is "Buy".
| Price Target | $265.88 |
| Price Target Difference | 12.55% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 6.51% |
| EPS Growth Forecast (5Y) | 15.81% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |
